Jeroen A Schouten

InstitutionRadboud university medical center
AddressThe
Netherlands
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in October 2020
    All Publications
    Bar chart showing 42 publications over 14 distinct years, with a maximum of 7 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kooistra EJ, van Berkel M, van Kempen NF, van Latum CRM, Bruse N, Frenzel T, van den Berg MJW, Schouten JA, Kox M, Pickkers P. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients. Crit Care. 2021 08 05; 25(1):281. PMID: 34353339.
      Citations: 4     Fields:    Translation:Humans
    2. Schouten J, De Waele J, Lanckohr C, Koulenti D, Haddad N, Rizk N, Sjövall F, Kanj SS. Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns. Int J Antimicrob Agents. 2021 Oct; 58(4):106409. PMID: 34339777.
      Citations: 1     Fields:    Translation:Humans
    3. Verweij PE, Brüggemann RJM, Azoulay E, Bassetti M, Blot S, Buil JB, Calandra T, Chiller T, Clancy CJ, Cornely OA, Depuydt P, Koehler P, Lagrou K, de Lange D, Lass-Flörl C, Lewis RE, Lortholary O, Liu PL, Maertens J, Nguyen MH, Patterson TF, Rijnders BJA, Rodriguez A, Rogers TR, Schouten JA, Wauters J, van de Veerdonk FL, Martin-Loeches I. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021 08; 47(8):819-834. PMID: 34160631.
      Citations: 10     Fields:    Translation:Humans
    4. van de Veerdonk FL, Brüggemann RJM, Vos S, De Hertogh G, Wauters J, Reijers MHE, Netea MG, Schouten JA, Verweij PE. COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion. Lancet Respir Med. 2021 07; 9(7):795-802. PMID: 34051176.
      Citations: 11     Fields:    Translation:Humans
    5. Citations: 9     Fields:    Translation:HumansCells
    6. Brüggemann RJ, Moes DJAR, van Rhee KP, van 't Veer NE, Koch BCP, van Rossum M, Windsant-van den Tweel AV, Reijers MHE, van Kimmenade RRJ, Rahamat-Langedoen JC, Rettig TCD, van Raalte R, van Paassen J, Polderman FN, van der Linden PD, Frenzel T, de Mast Q, Burger DM, Schouten J, van de Veerdonk FL, Pickkers P, Ter Heine R. Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals. Int J Antimicrob Agents. 2021 Mar; 57(3):106293. PMID: 33515687.
      Citations:    Fields:    Translation:Humans
    7. van Berkel M, Kox M, Frenzel T, Pickkers P, Schouten J. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? Crit Care. 2020 10 06; 24(1):600. PMID: 33023606.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    8. Sieswerda E, de Boer MGJ, Bonten MMJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, van de Garde EMW, Verheij TJ, van der Eerden MM, Prins JM, Wiersinga WJ. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Clin Microbiol Infect. 2021 Jan; 27(1):61-66. PMID: 33010444.
      Citations: 29     Fields:    Translation:Humans
    9. Verweij PE, Rijnders BJA, Brüggemann RJM, Azoulay E, Bassetti M, Blot S, Calandra T, Clancy CJ, Cornely OA, Chiller T, Depuydt P, Giacobbe DR, Janssen NAF, Kullberg BJ, Lagrou K, Lass-Flörl C, Lewis RE, Liu PW, Lortholary O, Maertens J, Martin-Loeches I, Nguyen MH, Patterson TF, Rogers TR, Schouten JA, Spriet I, Vanderbeke L, Wauters J, van de Veerdonk FL. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 Aug; 46(8):1524-1535. PMID: 32572532.
      Citations: 77     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    10. Kox M, Frenzel T, Schouten J, van de Veerdonk FL, Koenen HJPM, Pickkers P. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients. Crit Care. 2020 May 26; 24(1):263. PMID: 32456696.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health